Needham & Company Downgrades Imperva (IMPV) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/11/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
- AppLovin gains market share among e-commerce advertisers
Oppenheimer Remains Bullish on Imperva (IMPV) Following 1Q Beat
May 6, 2016 9:46 AM EDTOppenheimer maintained an Outperform rating on Imperva (NYSE: IMPV), and cut the price target to $60.00 (from $70.00), following the company's 1Q earnings report. Revenue came in at $59.8M, ahead of the consensus of $59.5M. EPS of $0.20, bested the Street's $0.28 estimate. 2Q16 revenues were guided... More
Imperva (IMPV) Tops Q1 EPS by 3c
May 5, 2016 4:24 PM EDTImperva (NYSE: IMPV) reported Q1 EPS of ($0.25), $0.03 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $59.8 million versus the consensus estimate of $59.62 million.
We had a great start to the year driven by the ongoing demand for our best-of-breed discovery,... More
